Key points
- Alpha-lipoic acid is a sulfur-containing compound involved in energy metabolism that exhibits both fat-soluble and water-soluble properties.
- The body can produce ALA; it is also found in small amounts in certain foods and can be used as a supplement.
- Its most extensively studied clinical use is for symptoms of diabetes-related peripheral neuropathy; the degree of benefit varies from person to person.
- The decision to use a supplement should be individualized, taking into account medications being used and metabolic status.
What is alpha-lipoic acid?
Alpha-lipoic acid (ALA or thioctic acid) acts as a cofactor in enzyme systems associated with energy production in mitochondria. It is part of the antioxidant network because it can cycle between its oxidized and reduced forms. However, this biochemical property does not mean that it provides clinical benefit in every disease; the results of human studies should be evaluated separately according to the intended use.
What does it do in the body?
- It assists enzymes involved in mitochondrial energy metabolism.
- It takes part in reactions that contribute to the oxidation-reduction balance.
- It participates in biochemical cycles associated with antioxidant systems such as glutathione, vitamin C, and vitamin E.
- Its effects on glucose metabolism and nerve tissue are being studied.
In which areas has it been studied?
ALA has been studied in relation to diabetic neuropathy, glucose metabolism, oxidative stress, liver health, and certain neurological conditions. The area with the largest body of clinical evidence is symptoms such as pain, burning, and numbness in diabetes-related peripheral neuropathy. Although meta-analyses suggest that symptoms may improve in some patients, the studies differ in duration, routes of administration, and methods. ALA does not replace diabetes treatment or blood sugar control.
For whom is it considered?
Supplementation may be considered by a physician for people who have neuropathic complaints, whose nutritional and metabolic risks are being evaluated together, or for whom support is being sought for a specific clinical goal. The decision should be based not only on symptoms, but on a combined assessment of the diagnosis, laboratory results, medications being used, kidney and liver function, and nutritional status.
Approach to use and dosing
Different oral and intravenous doses have been used in studies. The most appropriate dose varies according to the product formulation, intended use, coexisting conditions, and tolerability. A higher dose does not always mean better results. During clinical follow-up, changes in symptoms, blood sugar control, and possible side effects are evaluated together.
Safety and precautions
ALA is well tolerated by most people at appropriate doses. Nausea, stomach discomfort, or headache may occur. Blood sugar should be monitored more closely in people taking diabetes medications. Assessment for thiamine deficiency is important in cases of regular alcohol use or inadequate nutrition. The European Food Safety Authority has drawn attention to the possibility of rare insulin autoimmune syndrome in people with a genetic predisposition; use should be evaluated if unexplained symptoms of hypoglycemia develop.
Our clinic’s approach
We evaluate ALA not as a stand-alone “detox” or miracle antioxidant, but in terms of whether it will serve a specific clinical goal. Neuropathy, glucose metabolism, nutrition, and concomitant medications are examined together; goals that can be monitored are established, and unnecessary use that provides no benefit is not continued.
Frequently asked questions
Does ALA lower blood sugar?
Its effects on glucose metabolism have been studied; however, it is not used as a substitute for diabetes treatment. People taking medications need blood sugar monitoring because of a possible additional effect.
Is it beneficial for every type of neuropathy?
The most data pertain to diabetic peripheral neuropathy. In other neuropathies, the underlying cause should first be identified, and the level of evidence should be evaluated separately.
Related content
References
- National Center for Complementary and Integrative Health. Type 2 Diabetes and Dietary Supplements: What the Science Says.
- Hsieh RY et al. Effects of Oral Alpha-Lipoic Acid Treatment on Diabetic Polyneuropathy: A Meta-Analysis and Systematic Review.
- European Food Safety Authority. Food supplements and alpha-lipoic acid safety.
